| 000 | 01783 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515054754.0 | ||
| 264 | 0 | _c20070418 | |
| 008 | 200704s 0 0 fre d | ||
| 022 | _a0399-8320 | ||
| 024 | 7 |
_a10.1016/s0399-8320(07)89335-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAubourg, Alexandre | |
| 245 | 0 | 0 |
_a[Autoimmune thrombopenia associated with hepatitis B reactivation (reverse seroconversion) after autologous hematopoietic stem cell transplantation]. _h[electronic resource] |
| 260 |
_bGastroenterologie clinique et biologique _cJan 2007 |
||
| 300 |
_a97-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 |
_aHepatitis B _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunologic Factors _xadministration & dosage |
| 650 | 0 | 4 |
_aLymphoma _xtherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganophosphonates _xtherapeutic use |
| 650 | 0 | 4 |
_aPurpura, Thrombocytopenic, Idiopathic _xetiology |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aTransplantation, Autologous _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _ad'Alteroche, Louis | |
| 700 | 1 | _aSenecal, Delphine | |
| 700 | 1 | _aGaudy, Catherine | |
| 700 | 1 | _aBacq, Yannick | |
| 773 | 0 |
_tGastroenterologie clinique et biologique _gvol. 31 _gno. 1 _gp. 97-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0399-8320(07)89335-3 _zAvailable from publisher's website |
| 999 |
_c16833952 _d16833952 |
||